HGH Fragment 176-191 vs Lixisenatide

Head-to-head comparison of HGH Fragment 176-191 (Human Growth Hormone Fragment 176-191) and Lixisenatide (Exendin-4-derived GLP-1 receptor agonist) — benefits, dosing, side effects, research data, and where to buy.

PropertyHGH Fragment 176-191Lixisenatide
CategoryWeight ManagementWeight Management
Full NameHuman Growth Hormone Fragment 176-191Exendin-4-derived GLP-1 receptor agonist
Molecular Weight1817.12 g/mol4858 Da
Half-Life~30 minutes2-4 hours
Amino Acids1644
Typical Dose10-20 mcg daily
RouteSubcutaneous
Purity>98%≥98%
Studies Count45400
Research StatusActive ResearchApproved

HGH Fragment 176-191 Benefits

  • Targeted fat loss, no blood sugar impact, no IGF-1 elevation, inhibits lipogenesis, stimulates lipolysis, improved body composition

Lixisenatide Benefits

  • postprandial glucose control
  • modest weight loss
  • appetite reduction
  • short-acting option

HGH Fragment 176-191 Dosing

250-500 mcg subcutaneously 1-2 times daily on empty stomach. 12-16 week cycles typical in research.

Lixisenatide Dosing

10 mcg SC daily for 14 days|Increase to 20 mcg daily|Inject before the first meal of the day

HGH Fragment 176-191 Side Effects

  • Injection site irritation, headache, drowsiness. Does not affect blood sugar, insulin sensitivity, or elevate IGF-1.

Lixisenatide Side Effects

  • nausea
  • vomiting
  • hypoglycemia when combined with insulin

Research Overview

HGH Fragment 176-191

This 16-amino-acid fragment specifically targets adipose tissue via beta-3 adrenergic receptors. Works through a GH-receptor-independent pathway, explaining selective fat-loss properties without growth-promoting effects.

Lixisenatide

Lixisenatide produces small but measurable weight loss in diabetes trials while improving postprandial glucose excursions. Its shorter half-life makes it a useful reference compound for first-generation incretin mimetics.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

HGH Fragment 176-191 stacks with:

AOD-9604CJC-1295Ipamorelin

Lixisenatide stacks with:

basal-insulinmeal-plan
fat-lossgrowth-hormone-fragmentlipolysisbody-recompositionGLP-1RAshort-actingpostprandial-controlweight-loss-adjacent